Clinical Trial Update: Urolithin A in Patients With Previously Untreated Solid Tumors Receiving Immune Checkpoint Inhibitors [NA]

View source ↗

Summary

This entry reports a recruiting clinical trial evaluating urolithin A in patients with previously untreated solid tumors receiving immune checkpoint inhibitors.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma
• Non-small Cell Lung Cancer
• Solid Tumors

Drugs mentioned

• Urolithin A (Urolithin A)

Snippet

Sponsor: Goethe University | Conditions: Solid Cancer, Non-Small Cell Lung Cancer | NA | Status: RECRUITING